NCT05328674

Brief Summary

Clinical and comparative evaluation of the treatment results of arthroscopic reconstruction of cartilage defects in the knee joint with the use of autogenous cartilage graft with PRP GF (platelet-rich plasma with growth factors)

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 22, 2021

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

March 30, 2022

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 14, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 22, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 22, 2022

Completed
Last Updated

April 14, 2022

Status Verified

March 1, 2022

Enrollment Period

1 year

First QC Date

March 30, 2022

Last Update Submit

April 7, 2022

Conditions

Keywords

CartilageInjuryDamageDefectsTechniquesReconstruction

Outcome Measures

Primary Outcomes (19)

  • Visual Analogue Score

    Visual Analogue Score - subjective measure for acute and chronic pain. 100-mm VAS ratings of: * 0 to 4 mm can be considered no pain; * 5 to 44 mm, mild pain; * 45 to 74 mm, moderate pain; * 75 to 100 mm, severe pain.

    1 day

  • Visual Analogue Score

    Visual Analogue Score - subjective measure for acute and chronic pain. 100-mm VAS ratings of: * 0 to 4 mm can be considered no pain; * 5 to 44 mm, mild pain; * 45 to 74 mm, moderate pain; * 75 to 100 mm, severe pain.

    3 months after procedure

  • Visual Analogue Score

    Visual Analogue Score - subjective measure for acute and chronic pain. 100-mm VAS ratings of: * 0 to 4 mm can be considered no pain; * 5 to 44 mm, mild pain; * 45 to 74 mm, moderate pain; * 75 to 100 mm, severe pain.

    6 months after procedure

  • Tegner Activity Level Scale (TAS)

    The Tegner Activity Scale (TAS) aims to provide a standardized method in determining the level of activity prior to injury and level of activity post injury that can be documented on a numerical scale. The Tegner activity scale is a one-item score that graded activity based on work and sports activities on a scale of 0 to 10. Zero represents disability because of knee problems and 10 represents national or international level soccer.

    1 day

  • Tegner Activity Level Scale (TAS)

    The Tegner Activity Scale (TAS) aims to provide a standardized method in determining the level of activity prior to injury and level of activity post injury that can be documented on a numerical scale. The Tegner activity scale is a one-item score that graded activity based on work and sports activities on a scale of 0 to 10. Zero represents disability because of knee problems and 10 represents national or international level soccer.

    3 months after procedure

  • Tegner Activity Level Scale (TAS)

    The Tegner Activity Scale (TAS) aims to provide a standardized method in determining the level of activity prior to injury and level of activity post injury that can be documented on a numerical scale. The Tegner activity scale is a one-item score that graded activity based on work and sports activities on a scale of 0 to 10. Zero represents disability because of knee problems and 10 represents national or international level soccer.

    6 months after procedure

  • Tegner Lysholm Knee Scoring Scale

    The Tegner Lyshom Knee Scoring Scale is a patient-reported instrument that consists of subscales for pain, instability, locking, swelling, limp, stair climbing, squatting, and the need for support. Scores range from 0 (worse disability) to 100 (less disability). Grading the Tegner Lysholm Knee Scoring Scale: * \<65 - poor; * 65-83 - fair; * 84-90 - good; * \>90 - excellent.

    1 day

  • Tegner Lysholm Knee Scoring Scale

    The Tegner Lyshom Knee Scoring Scale is a patient-reported instrument that consists of subscales for pain, instability, locking, swelling, limp, stair climbing, squatting, and the need for support. Scores range from 0 (worse disability) to 100 (less disability). Grading the Tegner Lysholm Knee Scoring Scale: * \<65 - poor; * 65-83 - fair; * 84-90 - good; * \>90 - excellent.

    3 months after procedure

  • Tegner Lysholm Knee Scoring Scale

    The Tegner Lyshom Knee Scoring Scale is a patient-reported instrument that consists of subscales for pain, instability, locking, swelling, limp, stair climbing, squatting, and the need for support. Scores range from 0 (worse disability) to 100 (less disability). Grading the Tegner Lysholm Knee Scoring Scale: * \<65 - poor; * 65-83 - fair; * 84-90 - good; * \>90 - excellent.

    6 months after procedure

  • IKDC SUBJECTIVE KNEE EVALUATION FORM

    Interpreted as a measure of function, such that higher scores represent higher levels of function and lower levels of symptoms. A score of 100 is interpreted to mean no limitation with sporting activities or daily living and the complete absence of symptoms.

    1 day

  • IKDC SUBJECTIVE KNEE EVALUATION FORM

    Interpreted as a measure of function, such that higher scores represent higher levels of function and lower levels of symptoms. A score of 100 is interpreted to mean no limitation with sporting activities or daily living and the complete absence of symptoms.

    3 months after procedure

  • IKDC SUBJECTIVE KNEE EVALUATION FORM

    Interpreted as a measure of function, such that higher scores represent higher levels of function and lower levels of symptoms. A score of 100 is interpreted to mean no limitation with sporting activities or daily living and the complete absence of symptoms.

    6 months after procedure

  • Body Mass Index (BMI)

    BMI is interpreted using standard weight status categories: I : below 18.5 kg/m2 - underweight; II : 18.5 - 24.9 kg/m2 - healthy weight; III : 25.0 - 29.9 kg/m2 - overweight; IV : 30.0 kg/m2 and above - obesity.

    1 day

  • Body Mass Index (BMI)

    BMI is interpreted using standard weight status categories: I : below 18.5 kg/m2 - underweight; II : 18.5 - 24.9 kg/m2 - healthy weight; III : 25.0 - 29.9 kg/m2 - overweight; IV : 30.0 kg/m2 and above - obesity.

    3 months after procedure

  • Body Mass Index (BMI)

    BMI is interpreted using standard weight status categories: I : below 18.5 kg/m2 - underweight; II : 18.5 - 24.9 kg/m2 - healthy weight; III : 25.0 - 29.9 kg/m2 - overweight; IV : 30.0 kg/m2 and above - obesity.

    6 months after procedure

  • Magnetic resonance imaging (MRI)

    1,5 Tesli

    6 months after procedure

  • Ultrasonography (USG)

    Ultrasound examination on the apparatus with the option of elastometry

    6 months after procedure

  • Biomechanical examination

    On the Biodex 3 System measuring device

    3 months after procedure

  • Biomechanical examination

    On the Biodex 3 System measuring device

    6 months after procedure

Study Arms (2)

Microfracture method

ACTIVE COMPARATOR
Procedure: Arthroscopic reconstruction of the cartilage defects of the knee joint using the microfracture method

Method of autogenous PRP (Auto Cart-Arthrex) cartilage transplant

EXPERIMENTAL
Procedure: Arthroscopic reconstruction of cartilage defects in the knee joint with the use of autogenous cartilage transplant with PRP GF (platelet plasma with growth factor)

Interventions

Arthroscopic reconstruction of cartilage defects in the knee joint using an autogenous PRP GF cartilage transplant.

Method of autogenous PRP (Auto Cart-Arthrex) cartilage transplant

Arthroscopic reconstruction of the cartilage defects of the knee joint using the microfracture method.

Microfracture method

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-65 years;
  • Surgery for ACL damage to the knee joint;
  • Arthroscopic surgery;
  • No prior knee surgical interventions;
  • No additional pathologies in this anatomical area;
  • Informed consent of the patient to participate in the study.

You may not qualify if:

  • Age under 18 or over 65;
  • Previous surgical interventions in the examined anatomical area;
  • Additional pathologies in this area identified as part of preoperative diagnostics;
  • Damage to the second knee joint;
  • Failure to comply with the rigor of the same rehabilitation treatment protocol.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

eMKa MED Medical Center

Wroclaw, Dolnośląsk, 53-110, Poland

RECRUITING

MeSH Terms

Conditions

Knee InjuriesWounds and Injuries

Interventions

Intercellular Signaling Peptides and Proteins

Condition Hierarchy (Ancestors)

Leg Injuries

Intervention Hierarchy (Ancestors)

PeptidesAmino Acids, Peptides, and ProteinsProteinsBiological Factors

Central Study Contacts

Maciej Kentel, MD PhD

CONTACT

Kacper Kentel, Master's degree

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: comparison of the results of arthroscopic treatment of analogous areas of cartilage defects in the knee joint obtained in study groups using two methods: microfracture and autogenous PRP GF cartilage graft (Auto Cart - Arthrex method).
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 30, 2022

First Posted

April 14, 2022

Study Start

June 22, 2021

Primary Completion

June 22, 2022

Study Completion

June 22, 2022

Last Updated

April 14, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations